Correction: BMC Complement Altern Med 19, 260 (2019)

https://doi.org/10.1186/s12906-019-2629-y

Following publication of the original article [1], the authors reported an error in Fig. 1. The correct figure is given below.

Fig. 1
figure 1

Dose dependent inhibition of S. commune HAE by plaque reduction assay: a Uninfected Vero cells, b Vero cells infected with DENV2 (NGC strain) (80-100 PFU), c Infected cell after treated with Ribavirin (250 μg/ml), d, e and f infected cell after treated with S. commune HAE (2500 μg/ml, 1500 μg/ml and 500 μg/ml)

The original article [1] has been updated.